Fri, Dec 19, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 1.63% in December; Healthcare & Biotechnology Index up 13.79% in 2012 (+8.27% 2012)

Monday, January 14, 2013
Opalesque Industry Update: Hedge funds gained 1.63% in December, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index had positive returns in 10 out of 12 months in 2012, and was up 8.27% at year-end.

“Buoyant equity markets at the beginning of the month collided with fiscal cliff fears at mid-month, only to explode higher on December 31st,” says Sol Waksman, founder and president of BarclayHedge.

The Barclay Pacific Rim Equities Index was up 3.17% in December, Emerging Markets gained 2.87%, European Equities were up 2.24%, Equity Long Bias gained 2.04%, and Distressed Securities added 1.95%.

“Hedge fund returns outpaced the S&P 500 for a third consecutive month in December, but stilled lagged by 7.76 percent at year-end,” says Waksman.

Three of Barclay’s 18 hedge fund strategies lost ground in December. The Equity Short Bias Index dropped 5.97%, Technology lost 0.33%, and Equity Market Neutral slipped 0.06%.

The Healthcare & Biotechnology Index led all hedge fund strategies in 2012 with a 13.79% gain, Distressed Securities gained 12.05%, the European Equities Index was up 10.17%, Emerging Markets added 9.94%, Equity Long Bias was up 9.34%, and Fixed Income Arbitrage gained 9.33%.

“Now that the boomer generation has begun to swell the ranks of senior citizens and Obamacare is the law of the land, the outlook for healthcare and biotech appears to be bullish,” says Waksman.

The Equity Short Bias Index was the only losing hedge fund strategy in 2012, suffering a negative return of 24.18%. This is the biggest one-year loss for Equity Short Bias since BarclayHedge began tracking its performance in 1997. The previous record was a 23.95% loss in 2003.

The Barclay Fund of Funds Index gained 1.05% in December, and was up 4.60% in 2012.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und